Top
Note: You're navigating the results of models obtained with the previous release of IntOGen (2020). A new boostDM version corresponding to the current IntOGen release will be available soon.
IDH2 AML ×
Select a mutation to see further information
Mutation AA change Consequence type BoostDM score IntOGen frequency
15:90088702:T R140Q missense_variant 1.00 32
15:90088606:T R172K missense_variant 1.00 11
15:90088703:A R140W missense_variant 1.00 1
15:90088702:A R140L missense_variant 1.00 0
15:90088702:G R140P missense_variant 1.00 0
15:90088606:A R172M missense_variant 1.00 0
15:90088606:G R172T missense_variant 1.00 0
15:90088703:C R140G missense_variant 1.00 0
15:90088605:A R172S missense_variant 1.00 0
15:90088605:G R172S missense_variant 1.00 0
15:90088607:C R172G missense_variant 1.00 0
15:90088607:A R172W missense_variant 1.00 0
In silico saturation mutagenesis
Alt text Show figure caption
Cancer type Selected cancer type Mutational discovery Index Feature Complexity
(AML) Acute myeloid leukemia AML 0.97 0.07